The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Human apolipoprotein E. The complete amino acid sequence
Open accessAbstract
The amino acid sequence of human apolipoprotein E (apo-E) has been determined.Apo-E2, one of the major isoforms of apolipoprotein E, is a polypeptide of 299 amino acids having a calculated molecular weight of 34,145.The isoform apo-E3 differs from apo-E2 by a single amino acid substitution of arginine for cysteine at residue 158 (italicized).The sequqnce of apo-E2 is:HzN-Lys-Val-Glu-Gln-Ala-Val-Glu-Thr-Glu-Pro-Glu-Pro-Glu-Leu-Arg-Gln-Gln-Thr-Glu-Trp-Gln-Ser-Gly-Gln-Arg-Trp-Glu-Leu-Ala-Leu-Gly-Arg-Phe-Trp-Asp-Tyr-Leu-Arg-Trp-Val-Gln-%-Leu-Ser-Glu-Gln-Val-Gln-Glu-Glu-Leu-Leu-Ser-Ser-Gln-Val-Thr-Gln-Glu-Leu-Arg-Ala-Leu-Met-Asp-Glu-Thr-Met-Lys-Glu-Leu-Lys-Ala-Tyr-Lys-Ser-Glu-Leu-Glu-Glu-Gln-Leu-Thr-Pro-Val-Ala-Glu-Glu-Thr-Arg-Ala-Arg-Leu-Ser-Lys-Glu-Leu-Gln-Ala-Ala-Gln-Ala-Arg-Leu-Gly-Ala-Asp-Met-Glu-Asp-Val-Cys-Gly-Arg-Leu-Val-Gln-Tyr-Arg-Gly-Glu-Val-Gln-Ala-Met-Leu-Gly-Gln-Ser-Thr-Glu-Glu-Leu-Arg-Val-Arg-Leu-Ala-Ser-His-Leu-Arg-Lys-Leu-Arg-Lys-Arg-Leu-Leu-Arg-Asp-Ala-Asp-Asp-Leu-Gln-Lys-Cys-Leu-Ala-Val-Tyr-Gln-Ala-Gly-Ala-Arg-Glu-Gly-Ala-Glu-Arg-Gly-Leu-Ser-Ala-Ile-Arg-Glu-Arg-Leu-Gly-Pro-Leu-Val-Glu-Gln-Gly-Arg-Val-Arg-Ala-Ala-%-Val-Gly-Ser-Leu-Ala-Gly-Gln-Pro-Leu-Gln-Glu-Arg-Ala-Gln-Ala-Trp-Gly-Glu-Arg-Leu-Arg-Ala-Arg
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most common has a mutation of 158 Arg --Cys (13), but mutations of 145 Arg -* Cys (14) and 146 Lys --Gln (6) have also been reported in individuals with type III hyperlipoproteinemia.”
From Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. (1987) · cites this paper as [13]
In the citing paper
“Three variants ofapo E2 have been described.Each ofthese differs from apo E3 by a single amino acid substitution (6, 12- 14).”
From Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. (1987) · cites this paper as [13]
In the citing paper
“Secondary structure predictions (54,55) suggest that position 136 is part of an a-helix that extends between residues 130 and 150 (13,24), encompassing the receptor-binding domain from 140 to 150 (22).”
From Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. (1987) · cites this paper as [13]
In the citing paper
“The mature apoE protein consists of 299 amino acids and an 18amino acid signal peptide is removed post-translationally [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [17]
In the citing paper
“The low density lipoprotein (LDL) receptor binding region is situated in helix four between amino acids 136 and 150 [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [17]
In the citing paper
“Both codons 112 and 158 showed the amino acid cysteine (Cys) (shown in Fig. 3), which indicated that the isoform of apoE was apoE2/E2 [8, 9].”
In the citing paper
“In normal apoE3, peptide T15 is a 15-residue peptide encompassing residues 120-134 (23).”
From Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121–127 (1989) · cites this paper as [23]
In the citing paper
“This profile is similar to that for normal apoE3 (17, 23) except for the presence of a new peak (CBX) eluting at the column volume.”
From Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121–127 (1989) · cites this paper as [23]
Citations
Cites
Prediction of protein conformation
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a002 · Cited by 3,309
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a001 · Cited by 2,172
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Self-citationA molecular theory of lipid—protein interactions in the plasma lipoproteins
Segrest, J. P., Jackson, R. L., Morrisett, J. D., & Gotto, A. M. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80064-5 · Cited by 726
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Self-citationWeisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34284-9 · Cited by 616
Self-citationMarshall, R. (1972) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.41.070172.003325 · Cited by 604
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Disturbances in Lipid and Lipoprotein Metabolism
Bouchier, I. A. D. (1978) · Gut · doi:10.1136/gut.19.11.1088 · Cited by 495
Innerarity, T. L., & Mahley, R. W. (1978) · Biochemistry · doi:10.1021/bi00601a013 · Cited by 433
Self-citation
Research works printed but not linked: 2
- Mahley, 1977, Am. J. Pathol., 87, 205
- Utermann, 1980, Am. J. Hum. Genet., 32, 339
Cited by
Sorted by citations
Items 201–300 of 739
Apolipoprotein E and Neurological Disease: Therapeutic Potential and Pharmacogenomic Interactions
Laskowitz, D. T., & Vitek, M. P. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.8.959 · Cited by 58
Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E
Weisgraber, K. H., Pitas, R. E., & Mahley, R. W. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90212-7 · Cited by 58
Self-citationIntracellular modifications of human apolipoprotein E.
Zannis, V. I., vanderSpek, J. C., & Silverman, D. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67033-4 · Cited by 57
Minta, K., Brinkmalm, G., Janelidze, S., Sjödin, S., Portelius, E., Stomrud, E., Zetterberg, H., Blennow, K., Hansson, O., & Andréasson, U. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00585-7 · Cited by 57
Patsch, J. R. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80023-x · Cited by 56
Immunohistochemical localization of apolipoprotein E in human glial neoplasms.
Murakami, M., Ushio, Y., Morino, Y., Ohta, T., & Matsukado, Y. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113568 · Cited by 55
[49] Genetic polymorphism in human apolipoprotein E
Zannis, V. I. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)28109-4 · Cited by 55
Gregg, R. E., Ghiselli, G., & Brewer, H. B. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-5-969 · Cited by 55
Leon, A. S., Togashi, K., Rankinen, T., Després, J., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2003) · Metabolism · doi:10.1016/j.metabol.2003.08.013 · Cited by 54
The Role of Apolipoprotein E in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis
Zhang, H., Wu, J., & Zhu, J. (2010) · BioMed Research International · doi:10.1155/2010/357412 · Cited by 57
ApoE Induces Serum Paraoxonase PON1 Activity and Stability Similar to ApoA-I
Gaidukov, L., I, V. R., Yacobson, S., Rosenblat, M., Aviram, M., & Tawfik, D. S. (2009) · Biochemistry · doi:10.1021/bi9013227 · Cited by 54
Mercury, APOE, and children's neurodevelopment
Ng, S., Lin, C., Hwang, Y., Hsieh, W., Liao, H., & Chen, P. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.03.012 · Cited by 54
Lohse, P., Mann, W. A., Stein, E. A., & Brewer, H. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99249-5 · Cited by 54
Apolipoprotein E Polymorphism and Atherosclerosis
Kolovou, G. D., Daskalova, D. C., & Mikhailidis, D. P. (2003) · Angiology · doi:10.1177/000331970305400108 · Cited by 54
Chang, D. J., Paik, Y., Leren, T. P., Walker, D., Howlett, G. J., & Taylor, J. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38877-5 · Cited by 54
Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects.
Ferrières, J., Sing, C. F., Roy, M., Davignon, J., & Lussier‐Cacan, S. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1553 · Cited by 53
Eichner, J. E., Kuller, L. H., Ferrell, R. E., Meilahn, E. N., & Kamboh, M. I. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.3.379 · Cited by 54
Detection of DNA hybridization on chemically modified graphene platforms
Giovanni, M., Bonanni, A., & Pumera, M. (2011) · The Analyst · doi:10.1039/c1an15910k · Cited by 53
Chromosomal localization of the human apoprotein ci gene and of a polymorphic apoprotein AII gene
Knott, T. J., Eddy, R. L., Robertson, M. E., Priestley, L. M., Scott, J., & Shows, T. B. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80368-x · Cited by 53
MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism
Vuu, Y. M., Roberts, C.-T., & Rastegar, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044218 · Cited by 55
Flowers, S. A., Grant, O. C., Woods, R. J., & Rebeck, G. W. (2020) · Glycobiology · doi:10.1093/glycob/cwz084 · Cited by 52
Marmillot, P., Rao, M. N., Liu, Q., & Lakshman, M. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90136-1 · Cited by 50
Bradley, W. A., Gilliam, E. B., Gotto, A. M., & Gianturco, S. H. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91927-1 · Cited by 52
Pauw, M. D., Vanloo, B., Weisgraber, K. H., & Rosseneu, M. (1995) · Biochemistry · doi:10.1021/bi00034a030 · Cited by 50
Self-citationMezdour, H., Barthelemy-Clavey, V., Kora, I., Koffigan, M., Barkia, A., & Fruchart, J. (1987) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(87)80022-1 · Cited by 51
Maezawa, I., Jin, L., Woltjer, R. L., Maeda, N., Martin, G. M., Montine, T. J., & Montine, K. S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02818.x · Cited by 51
Apolipoprotein E2/E3/E4 genotyping with agarose gels
Dallinga‐Thie, G. M., Trip, M. V. L.-S., Kock, L. A., & de Bruin, T. W. A. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.73 · Cited by 49
Zerba, K. E., Ferrell, R. E., & Sing, C. F. (2000) · Human Genetics · doi:10.1007/s004390000394 · Cited by 49
Segelke, B. W., Forstner, M., Knapp, M., Trakhanov, S. D., Parkin, S., Newhouse, Y. M., Bellamy, H. D., Weisgraber, K. H., & Rupp, B. (2000) · Protein Science · doi:10.1110/ps.9.5.886 · Cited by 47
Self-citationApoE Production in Human Monocytes and Its Regulation by Inflammatory Cytokines
Braesch‐Andersen, S., Paulie, S., Smedman, C., Mia, S., & Kumagai‐Braesch, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079908 · Cited by 49
Huang, Y. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390924 · Cited by 53
Kassam, I., Gagnon, F., & Cusimano, M. D. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310500 · Cited by 48
Hubacek, J. A., Pitha, J. V., Škodová, Z., Poledne, R., Lánská, V., Waterworth, D. M., Humphries, S. E., & Talmud, P. J. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00025-0 · Cited by 46
Main, B. F., Jones, P. J. H., MacGillivray, R., & Banfield, D. K. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42257-6 · Cited by 48
Improved phenotyping of apolipoprotein E: application to population frequency distribution
Hill, J. S., & Pritchard, P. H. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.11.1871 · Cited by 48
Raulin, A.-C., Kraft, L., Al-Hilaly, Y. K., Xue, W.-F., McGeehan, J. E., Atack, J. R., & Serpell, L. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.019 · Cited by 47
From beta amyloid to altered proteostasis in Alzheimer’s disease
Bruni, A. C., Bernardi, L., & Gabelli, C. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101126 · Cited by 47
Contois, J. H., Anamani, D. E., & Tsongalis, G. J. (1996) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30290-7 · Cited by 45
Wallis, S. C., Rogne, S., Gill, L., Markham, A. F., Edge, M., Woods, D. E., Williamson, R., & Humphries, S. E. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01748.x · Cited by 46
Giannisis, A., Al-Grety, A., Carlsson, H., Patra, K., Twohig, D., Sando, S. B., Lauridsen, C., Berge, G., Grøntvedt, G. R., Bråthen, G., et al. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01058-9 · Cited by 46
Tsoi, L.-M., Wong, K., Liu, Y.-M., & Ho, Y.-Y. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.019 · Cited by 46
APOE polymorphism affects episodic memory among non demented elderly subjects
Blasi, S. D., Montesanto, A., Martino, C., Dato, S., Rango, F. D., Bruni, A. C., Mari, V., Feraco, E., & Passarino, G. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.11.005 · Cited by 45
Personalized nutrition for the prevention of cardiovascular disease: a future perspective
Lovegrove, J. A., & Gitau, R. (2008) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00889.x · Cited by 46
Explorative and targeted neuroproteomics in Alzheimer's disease
Brinkmalm, A., Portelius, E., Öhrfelt, A., Brinkmalm, G., Andréasson, U., Gobom, J., Blennow, K., & Zetterberg, H. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.01.009 · Cited by 45
Expression of ApoE Gene in Chinese Hamster Cells with a Reversible Defect in O-Glycosylation
Zanni, E. E., Kouvatsi, A., Hadzopoulou‐Cladaras, M., Krieger, M., & Zannis, V. I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60504-6 · Cited by 45
Mastana, S. S., Calderón, R., Peña, J. A., Reddy, P. H., & Papiha, S. S. (1998) · Annals of Human Biology · doi:10.1080/03014469800005512 · Cited by 45
Apolipoprotein E: A pharmacogenetic target for the treatment of Alzheimer's disease*
Poirier, J. (1999) · Molecular Diagnosis · doi:10.1016/s1084-8592(99)80010-1 · Cited by 44
Genetic Epidemiology of Alzheimer Disease
Slooter, A. J. C., & van Duijn, C. M. (1997) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017933 · Cited by 44
Ong, Q.-R., Chan, E. S., Lim, M.-L., Cole, G. M., & Wong, B.-S. (2014) · Scientific Reports · doi:10.1038/srep03754 · Cited by 44
Leren, T. P., Bbøresen, A., Berg, K., Hjermann, I., & Luren, P. (1985) · Clinical Genetics · doi:10.1111/j.1399-0004.1985.tb00231.x · Cited by 43
(1993) · PubMed · Cited by 43
Apolipoprotein E and atherosclerosis in Alaska Natives
Scheer, W. D., Boudreau, D. A., Malcom, G. T., & Middaugh, J. P. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05483-y · Cited by 43
Houlston, R. S., Snowden, C. P., Green, F. R., Alberti, K. G. M. M., & Humphries, S. E. (1989) · Human Genetics · doi:10.1007/bf00291382 · Cited by 43
Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer
Mrkonjic, M., Chappell, E., Pethe, V. V., Manno, M., Daftary, D., Greenwood, C. M. T., Gallinger, S., Zanke, B. W., Knight, J. A., & Bapat, B. V. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605097 · Cited by 43
Sauer, I., Nikolenko, H., Keller, S., Ajaj, K. A., Bienert, M., & Dathe, M. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.017 · Cited by 42
Sofat, R., Cooper, J. A., Kumari, M., Casas, J. P., Mitchell, J. P., Acharya, J., Thom, S., Hughes, A. D., Humphries, S. E., & Hingorani, A. D. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002146 · Cited by 42
James, M. L., Blessing, R., Bennett, E. R., & Laskowitz, D. T. (2009) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2008.09.012 · Cited by 41
Only multimers of a synthetic peptide of human apolipoprotein E are biologically active
Dyer, C. A., Smith, R. S., & Curtiss, L. K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98578-9 · Cited by 41
The Role of Apolipoprotein E Isoforms in Alzheimer’s Disease
Roda, A. R., Montoliu‐Gaya, L., & Villegas, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180740 · Cited by 41
Salero, E., Giménez, C., & Zafra, F. (2003) · Biochemical Journal · doi:10.1042/bj20021142 · Cited by 39
Cardona, F., Morcillo, S., Gonzalo‐Marín, M., & Tinahones, F. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1912 · Cited by 40
Apolipoprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays
Bachorik, P. S., & Kwiterovich, P. O. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90265-3 · Cited by 40
Wu, C. C., & Chen, G. C. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90036-5 · Cited by 40
Wardell, M., Rall, S., Schaefer, E., Kane, J., & Weisgraber, K. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42076-0 · Cited by 40
Self-citationCOVID-19 as a Risk Factor for Alzheimer’s Disease
Golzari-Sorkheh, M., Weaver, D. F., & Reed, M. A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220800 · Cited by 39
Multi-functional role of apolipoprotein E in neurodegenerative diseases
Islam, S., Noorani, A. A., Sun, Y., Michikawa, M., & Zou, K. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1535280 · Cited by 43
Type III Hyperlipoproteinemia: Still Worth Considering?
Blum, C. B. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.07.007 · Cited by 39
Weisgraber, K. H., Newhouse, Y. M., & Mahley, R. W. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81003-9 · Cited by 39
Self-citationHuman Low Density Lipoprotein Receptor Fragment
Simmons, T., Newhouse, Y. M., Arnold, K. S., Innerarity, T. L., & Weisgraber, K. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25531 · Cited by 37
Self-citationUtermann, G., Weisgraber, K. H., Weber, W., & Mahley, R. W. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37811-1 · Cited by 39
Self-citationThe Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
Chernick, D., Zhong, R., & Li, L. (2020) · Biomolecules · doi:10.3390/biom10091276 · Cited by 39
Lahoz, C., Osgood, D. P., Wilson, P. W., Schaefer, E. J., & Ordovás, J. M. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.11.1817 · Cited by 37
Concerning the structure of apoE
Frieden, C., & Garai, K. (2013) · Protein Science · doi:10.1002/pro.2379 · Cited by 39
Apolipoprotein E: phospholipid binding studies with synthetic peptides from the carboxyl terminus
Sparrow, J. T., Sparrow, D. A., Fernando, G. J. P., Culwell, A. R., Kovar, M., & Gotto, A. M. (1992) · Biochemistry · doi:10.1021/bi00119a015 · Cited by 38
Lalazar (1989) · doi:10.1016/s0021-9258(18)81806-3 · Cited by 238
Self-citationMartínez-Oliván, J., Arias‐Moreno, X., Velázquez‐Campoy, A., Millet, Ó., & Sancho, J. (2014) · FEBS Journal · doi:10.1111/febs.12721 · Cited by 37
Setzer, M., Hermann, E. J., Seifert, V., & Marquardt, G. (2008) · Spine · doi:10.1097/brs.0b013e3181657cf7 · Cited by 37
Setzer, M., Vrionis, F. D., Hermann, E. J., Seifert, V., & Marquardt, G. (2009) · Journal of Neurosurgery Spine · doi:10.3171/2009.7.spine08667 · Cited by 37
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E
Rye, K.-A., Bright, R., Psaltis, M., & Barter, P. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500525-jlr200 · Cited by 33
Abnormalities of Apolipoprotein E in the Acquired Immunodeficiency Syndrome
Grünfeld, C., Doerrler, W. T., Pang, M., Jensen, P., Weisgraber, K. H., & Feingold, K. R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4366 · Cited by 37
Self-citationHackler, R., Schäfer, J., Motzny, S., Brand, S., Kleine, T. O., Kaffarnik, H., & Steinmetz, A. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40122-1 · Cited by 37
Disorders of lipid transport—Update 1983
Schonfeld, G. (1983) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(83)90025-7 · Cited by 37
Apolipoprotein E Phenotyping: A Word of Caution
Wenham, P. R., Sedky, A., & Spooner, R. J. (1991) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329102800610 · Cited by 36
A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits.
Yamada, T., Kakihara, T., Gejyo, F., & Okada, M. (1994) · PubMed · Cited by 37
Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis.
Vrablı́k, M., Češka, R., & Hořínek, A. (2001) · PubMed · Cited by 36
Lefevre, M., Ginsberg, H. N., Kris‐Etherton, P. M., Elmer, P. J., Stewart, P. W., Ershow, A. G., Pearson, T. A., Roheim, P. S., Ramakrishnan, R., Derr, J., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2914 · Cited by 36
The contribution of α‐helices to the surface activities of proteins
Krebs, K. E., & Phillips, M. C. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)80748-6 · Cited by 36
Passarella, D., Ciampi, S., Liberto, V. D., Zuccarini, M., Ronci, M., Medoro, A., Foderà, E., Frinchi, M., Mignogna, D., Russo, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168921 · Cited by 38
Perugini, M. A., Schuck, P., & Howlett, G. J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03319.x · Cited by 35
The neurobiology of APOE in schizophrenia and mood disorders
Gibbons, A. S. (2010) · Frontiers in bioscience · doi:10.2741/3729 · Cited by 35
Pharmacogenetics of Target Genes Across the Warfarin Pharmacological Pathway
Lal, S., Jada, S. R., Xiang, X., Lim, W., Lee, E. J. D., & Chowbay, B. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645120-00004 · Cited by 35
Ha, S.-K., Park, H. S., Kim, K. W., Kim, S. J., Kim, D.-H., Kim, J. H., Lee, H. Y., & Han, D. S. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.9.2144 · Cited by 34
Simpson, R. J., Connolly, L. M., Eddes, J. S., Pereira, J. J., Moritz, R. L., & Reid, G. E. (2000) · Electrophoresis · doi:10.1002/(sici)1522-2683(20000501)21:9 · Cited by 205
Low-density lipoprotein cholesterol responsiveness to diet in normolipidemic subjects
Cobb, M. M., & RISCH, N. J. (1993) · Metabolism · doi:10.1016/0026-0495(93)90164-j · Cited by 35
Synthesis of Apolipoprotein E by Peripheral Tissues
Williams, D. L., Dawson, P. A., Newman, T. C., & Rudel, L. L. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb11861.x · Cited by 34
Apolipoprotein E Deficiency Leads to Cutaneous Foam Cell Formation in Mice
Feingold, K. R., Elias, P. M., Mao-Qiang, M. A. N., Fartasch, M., Zhang, S. H., & Maeda, N. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12612790 · Cited by 34
Musliner, T. A., McVicker, K. M., Iosefa, J. F., & Krauss, R. M. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.4.408 · Cited by 34
Type III Hyperlipoproteinemia: A Focus on Lipoprotein Receptor-Apolipoprotein E2 Interactions
Innerarity, T. L., Hui, D. Y., Bersot, T. P., & Mahley, R. W. (1986) · Springer eBooks · doi:10.1007/978-1-4684-1262-8_24 · Cited by 34
Self-citationApolipoprotein E Gene Polymorphism And Its Effect On Plasma Lipids In Arteriosclerosis
Zende, P. D. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/6195.3455 · Cited by 34
Cerebral lipid deposition in aged apolipoprotein-E-deficient mice.
Walker, L. C., Parker, C. A., Lipinski, W. J., Callahan, M. J., Carroll, R. T., Gandy, S., Smith, J. D., Jucker, M., & Bisgaier, C. L. (1997) · Europe PMC (PubMed Central) · Cited by 33
Metadata
- Authors
- Rall, S. C., Weisgraber, K. H., & Mahley, R. W.
- ORCID
- Mahley, R W
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1982-04
- Volume
- 257
- Issue
- 8
- Pages
- 4171-4178
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1736154854
- Cited by
- 741
- References
- 38
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 9 · 2023: 13 · 2022: 16 · 2021: 17 · 2020: 12 · 2019: 14 · 2018: 11 · 2017: 7 · 2016: 10 · 2015: 11 · 2014: 21 · 2013: 19 · 2012: 10
- FWCI
- 40.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- apolipoprotein E, amino acid sequence, apolipoprotein E isoforms, single amino acid substitution, protein sequences
- MeSH terms
- Amino Acid Sequence, Apolipoproteins, Apolipoproteins E, Carboxypeptidases, Cyanogen Bromide, Humans, Lipoproteins, LDL, Models, Molecular, Molecular Weight, Peptide Fragments, Protein Conformation, Carboxypeptidases A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review